Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
GlobeNewswire, Inc.
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on...
Global Emergency Call to Action: One Hour for Our Colleagues: A Rolling Global Healthcare Action
EIN Presswire
Doctors Against Genocide (DAG) calls on healthcare to join a rolling global One Hour of Action on Wednesday from 12:00–1:00 PM local time in every country.
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
GlobeNewswire, Inc.
Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing Amdocs AI Governance Leadership and $320 Million...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
GlobeNewswire, Inc.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
Israel Launches First Regulatory Sandbox for Artificial Intelligence in Healthcare
EIN Presswire
Three Israeli HealthTech Companies Selected to Advance Autonomous AI Systems for Pregnancy Care, Heart Failure Management, and Home Ultrasound JERUSALEM, ISRAEL, July 13, 2026 /EINPresswire.com/ -- The Israel Innovation Authority and the...
Israel Innovation Authority Invests Approx. NIS 70 Million in National Infrastructure for AI Models Based on Bio Data
EIN Presswire
New Israel BioToken Factory Initiative (IBFI) Brings Together NVIDIA, Teva, Sheba Medical Center, Startups and Universities to Develop Next Generation of Bio AI JERUSALEM, ISRAEL, July 12, 2026 /EINPresswire.com/ -- The Israel Innovation...
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
GlobeNewswire, Inc.
FDA grant of RMAT designation to Allocetra™ reinforces the potential of this program to deliver a meaningful, disease-modifying impact in age-related primary knee osteoarthritis, where patients face declined quality-of-life and limited treatment...
Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
GlobeNewswire, Inc.
EUR ~8M grant supports the late-stage clinical development of Omnix’s antimicrobial OMN6 Leading European partners join forces to advance OMN6 for the treatment of life-threatening hospital-acquired infections JERUSALEM, Israel, July 13, 2026 --...
PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets
GlobeNewswire, Inc.
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced the expansion of DeepSolar Predict™, the Company’s AI-driven renewable energy revenue optimization platform, with...
Presidential Spokesperson Vincent Magwenya: Media briefing statement
South African Government
Over the last two months, we have observed a sustained campaign that seeks to isolate South Africa from the rest of the African continent, under the guise of protesting against the recent wave of anti-illegal migration protest that we have...
Diaz-Balart Floor Remarks on H.R. 8595, National Security, Department of State, and Related Programs Appropriations Act, 2027 (As Prepared for the Record)
U.S. House Committee on Appropriations
Mr. Chair, I am pleased to present the Fiscal Year 2027 National Security, Department of State, and Related Programs appropriations bill to the House for consideration and approval.
ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
GlobeNewswire, Inc.
ENvue Targeting Combined $10 Billion+ Enteral Feeding and Vascular Access Market Opportunity* ENvue Drive™ Demonstration Marks First Step Toward a New Generation of Intelligent Bedside Procedures and Integrates ENvue’s Proprietary AI Navigation...
Pulsenmore Expands Home Ultrasound Clinical Utility, Backed by New Clinical Evidence
EIN Presswire
2 independent peer-reviewed studies validate remote BPP assessment, supporting strategy to expand its platform through scalable SaaS applications.
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
GlobeNewswire, Inc.
Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine platform designed to reduce risk and...
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
GlobeNewswire, Inc.
- The ADMIRE study, by treating immunocompromised patients, builds on the momentum of Alpha Tau's ReSTART pivotal trial for recurrent cSCC, which recently completed patient enrollment, under which the Banner MD Anderson team, led by Dr. Samuels,...
Odysight.ai Receives Purchase Order from Elbit Systems on Behalf of the Israeli Ministry of Defense for Deployment of Its Vision-Based Prognostics and Health Management System
GlobeNewswire, Inc.
The purchase order, valued at approximately $0.3 million (NIS 1.0 million), expands Odysight.ai’s operational portfolio and may lead to wide deployment across the Israeli Defense Forces upon successful completion Ramat Gan, Israel, July 08, 2026...
UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103
GlobeNewswire, Inc.
PRINCETON, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has...
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
GlobeNewswire, Inc.
ZURICH, July 15, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, today announced that the Brazilian Patent and Trademark Office has issued...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY
GlobeNewswire, Inc.
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.